Next Article in Journal
Heterocyclic Molecular Targeted Drugs and Nanomedicines for Cancer: Recent Advances and Challenges
Next Article in Special Issue
Toward Stability Enhancement of NTS1R-Targeted Radioligands: Structural Interventions on [99mTc]Tc-DT1
Previous Article in Journal
The Evolution and Recent Trends in Acoustic Targeting of Encapsulated Drugs to Solid Tumors: Strategies beyond Sonoporation
Previous Article in Special Issue
Angiotensin II Receptor Blockers Reduce Tau/Aß42 Ratio: A Cerebrospinal Fluid Biomarkers’ Case-Control Study
 
 
Article

Article Versions Notes

Pharmaceutics 2023, 15(6), 1704; https://doi.org/10.3390/pharmaceutics15061704
Action Date Notes Link
article pdf uploaded. 10 June 2023 10:49 CEST Version of Record https://www.mdpi.com/1999-4923/15/6/1704/pdf-vor
article supplementary file uploaded. 10 June 2023 10:49 CEST - https://www.mdpi.com/1999-4923/15/6/1704#supplementary
article xml file uploaded 12 June 2023 15:42 CEST Original file -
article xml uploaded. 12 June 2023 15:42 CEST Update https://www.mdpi.com/1999-4923/15/6/1704/xml
article pdf uploaded. 12 June 2023 15:43 CEST Updated version of record https://www.mdpi.com/1999-4923/15/6/1704/pdf
article html file updated 12 June 2023 15:44 CEST Original file -
article html file updated 12 June 2023 15:44 CEST Update -
article html file updated 20 June 2023 21:46 CEST Update https://www.mdpi.com/1999-4923/15/6/1704/html
Back to TopTop